Scott Toner is the current Senior Vice President of Commercial at Proteon Therapeutics. Scott has previously served as a Board Member for the American Association of Kidney Patients from September 2013 to August 2020. In April 2019, they became the President and Founder of BridgeView Strategies, a boutique consulting practice that supports biotechnology, pharmaceutical, and device companies with the development of commercialization strategies and launch execution. From June 2015 to April 2019, Toner was the Sr. Vice President Commercial at Proteon Therapeutics where they provided commercial leadership and developed a cross-functional strategy for the launch of a biopharmaceutical product administered during surgery intended to improve vascular access outcomes in patients requiring chronic hemodialysis. Prior to that, they served as President of Bear Hill Consulting from December 2012 to April 2014 and as Sr. Director Pipeline Marketing at Reata Pharmaceuticals from March 2011 to December 2012. Toner began their career in 2007 as the Executive Director of Marketing at AMAG Pharmaceuticals and held that position until October 2010.
Scott Toner attended Ithaca College, where they earned a BA. Scott then went on to earn an MBA from Drexel University - LeBow College of Business, with a concentration in business.
Their manager is Timothy P. Noyes, President and Chief Executive Officer. Some of their coworkers include George Eldridge - Senior Vice President and Chief Financial Officer, Bradley Hartman - Vice President, People, and Marco Wong - Medical Director.
Sign up to view 0 direct reports
Get started